spacer
home > ict > current issue
PUBLICATIONS

International Clinical Trials

ict
Summer 2021

   
Text
PDF
bullet
Features
Clinical Trial Supply Chains Accelerated by Labelling Innovation

Steve Ellison at PRISYM ID

PRISYM ID explains how to speed up your clinical trial labelling processes as part of a cohesive supply chain
 
view
download pdf
The Real-World Scenario

ICT discusses with UBC the impact of real-world data on the pharmaceutical industry, and where the future of this evidence will lead
 
view
download pdf


Wellbeing in Drug Delivery Marketing

Paul Williamson at Realia Marketing

When your day job is focused on improving health outcomes for others, there isn’t always the time to look after yourself. A panel of experts discussed why looking after yourself is integral to looking after your strategy in the drug delivery marketing field
 
view
download pdf
Pandemic Reflections on Whistleblowing Law in the UK

Paula Chan at BDBF

What can employees or workers do in order to gain the protection of whistleblowing law, and what should they do if they are victimised?
 
view
download pdf
Future Factories – Optimising Operations

Perry Zalevsky at AVEVA

The next generation of pharma factories is as much a digital entity as it is a mechanical one
 
view
download pdf
Achieving Flexibility in Clinical Contract Manufacturing

Katie Farley at MasterControl

The pharma industry relies on quick, effective decision-making from its leaders. To improve efficiency, businesses should utilise contemporary digital solutions in manufacturing
 
view
download pdf
bullet
Trial Designs
Top 10 Factors to Design and Deploy a Decentralised Clinical Trial
 
Dr Isaac R Rodriguez-Chavez at ICON

The design of a clinical trial can have a definitive impact on the success of approval, but there isn’t just an advantage to be gained through regulatory angles, trial design can have a big impact on the patient
 
view
download pdf
How Contingency Plans Became the New Normal

Anthony Poynton at Premier Research

Understanding how to run clinical trials remotely, and still deliver valid results, has progressed from an interim step to the way we do business. Employing suitable strategies to mitigate and manage risk means first learning how to leverage mHealth
 
view
download pdf
Adapt and Update: The Benefits of Bayesian

Dr Yannis Jemiai, Chief Scientific Officer at Cytel, discusses the impact of Bayesian and adaptive clinical trial designs amid COVID-19, and glances to their expanded future adoption post-pandemic
 
view
download pdf
Smart Home Devices Foster the Next Generation of Decentralised Clinical Trials

Tom Rhoads at Spencer Health Solutions

To better engage with patients, clinical trial providers are using technology and digital solutions to bring healthcare into participants’ homes
 
view
download pdf
Clinical Trial Design and Build

Steven Benham at Formedix

Advanced, all-in-one, cloud-based clinical metadata repositories are helping to standardise clinical study design and build, increase throughput, and decrease costs
 
view
download pdf
Anti-Infective Development Requires a New Approach to Clinical Trial Design

Jonathan Andrus at Clinical Ink

Lessons learned from deploying decentralised trials during COVID-19 are expected to carry through into future practices of the industry
 
view
download pdf
bullet
Technology in Trials
Immediate Impact

Liz Brennan at Wellington Eye Clinic

As a result of the COVID-19 pandemic, 70% of all clinical trials are behind schedule. There is a fervent demand for CROs and site-level changes to help streamline clinical trials
 
view
download pdf
How AI Is Helping Speed Drugs to Market Through Simulating Trials

Luca Emili at InSilicoTrials Technologies SpA

Product approvals can depend on numerous elements of a trial coming together, but by simulating trials in silico, the pharmaceutical industry can save time and costs
 
view
download pdf
Evolution and Revolution in Site Management

Emil Hoeck at Signant Health

While virtual and decentralised trials continue to proliferate and evolve, challenges still remain for sitebased trials. A novel approach to clinical site monitoring could redefine the future of medical research
 
view
download pdf
The Power of AI to Change the Rare Disease Paradigm

Allison Tyler and Wout Brusselaers at Deep 6 AI

Using AI, precision matching research criteria to patient characteristics can solve recruitment shortages in minutes rather than in months
 
view
download pdf
bullet
Patient Adherence and Engagement
The Barometer of Engagement

Bernard Vrijens at AARDEX Group

Building sustainable patient-centric trials to weather the storm of COVID-19 involves the utilisation of smart connected devices and packaging to reduce the burden on patients
 
view
download pdf
Patient Engagement in the New Age of Clinical Trials

Barbara Lopez Kunz and Courtney Granville at DIA

Patient engagement has become common practice within clinical trials. However, work must continue to define the most high-value elements across the therapeutic development ecosystem – those that drive the greatest efficiency in bringing safe and effective approaches to patients
 
view
download pdf
   
spacer


Published quarterly in
February, May,
August, and November

News and Press Releases

Catalent to Acquire RheinCell Therapeutics, Strengthening a Path Towards Industrialization of Induced Pluripotent Stem Cell-based Therapies

SOMERSET, N.J. – June 24, 2021 — Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it has reached an agreement to acquire RheinCell Therapeutics GmbH, a developer and manufacturer of GMP-grade human induced pluripotent stem cells (iPSCs).
More info >>

White Papers

The Use of Stainless Steel Equipment Within Laboratories and Clean Rooms

Teknomek Ltd

Teknomek explains why stainless steel is the material of choice for laboratories and hygienic manufacturing.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement